BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33558138)

  • 1. Integrin expression in correlation to clinicopathological features and prognosis of prostate cancer: A systematic review and meta-analysis.
    Drivalos A; Emmanouil G; Gavriatopoulou M; Terpos E; Sergentanis TN; Psaltopoulou T
    Urol Oncol; 2021 Apr; 39(4):221-232. PubMed ID: 33558138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA).
    Cao Z; Wei L; Zhu W; Yao X
    Medicine (Baltimore); 2018 Mar; 97(12):e0182. PubMed ID: 29561434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinicopathological significance and prognostic value of programmed death-ligand 1 in prostate cancer: a meta-analysis of 3133 patients.
    Shen H; Liu J; Sun G; Yan L; Li Q; Wang Z; Xie L
    Aging (Albany NY); 2020 Dec; 13(2):2279-2293. PubMed ID: 33318295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Hemoglobin in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.
    Mori K; Janisch F; Mostafaei H; Lysenko I; Karakiewicz PI; Enikeev DV; Briganti A; Kimura S; Egawa S; Shariat SF
    Clin Genitourin Cancer; 2020 Aug; 18(4):e402-e409. PubMed ID: 32007439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y
    World J Urol; 2020 Jan; 38(1):129-142. PubMed ID: 30919100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis.
    Li Y; Huang Q; Zhou Y; He M; Chen J; Gao Y; Wang X
    Front Pharmacol; 2018; 9():1494. PubMed ID: 30733677
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Qu W; Zhao H; Yuan J
    BMC Cancer; 2019 Jul; 19(1):716. PubMed ID: 31324162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Impact of Intraductal Carcinoma of the Prostate: A Systematic Review and Meta-Analysis.
    Miura N; Mori K; Mostafaei H; Quhal F; Motlagh RS; Pradere B; Laukhtina E; D'Andrea D; Saika T; Shariat SF
    J Urol; 2020 Nov; 204(5):909-917. PubMed ID: 32698712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expression.
    Hu Y; Wu Q; Gao J; Zhang Y; Wang Y
    BMC Urol; 2019 Jul; 19(1):67. PubMed ID: 31324239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of intraductal carcinoma of the prostate is closely associated with poor prognosis: a systematic review and meta-analysis.
    Zhang YC; Sun GL; Ma DL; Wei C; Shang HJ; Liu Z; Li R; Wang T; Wang SG; Liu JH; Liu XM
    Asian J Androl; 2021; 23(1):103-108. PubMed ID: 32496222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between integrin expression and prognosis in localized prostate cancer.
    Pontes-Júnior J; Reis ST; de Oliveira LC; Sant'anna AC; Dall'oglio MF; Antunes AA; Ribeiro-Filho LA; Carvalho PA; Cury J; Srougi M; Leite KR
    Prostate; 2010 Aug; 70(11):1189-95. PubMed ID: 20564421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis.
    Cao J; Zhu X; Zhao X; Li XF; Xu R
    PLoS One; 2016; 11(7):e0158770. PubMed ID: 27368058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review and meta-analysis of prognostic impact of different Gleason patterns in ISUP grade group 4.
    Mori K; Miura N; Comperat E; Nikles S; Pang KH; Misrai V; Gomez Rivas J; Papalia R; Shariat SF; Esperto F; Pradere B
    Minerva Urol Nephrol; 2021 Feb; 73(1):42-49. PubMed ID: 32432435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between Selenium and Prostate Cancer: a Systematic Review and Meta-Analysis.
    Sayehmiri K; Azami M; Mohammadi Y; Soleymani A; Tardeh Z
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1431-1437. PubMed ID: 29936712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
    Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
    Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-Analysis of 13,140 Patients.
    Fahmy O; Khairul-Asri MG; Schubert T; Renninger M; Stenzl A; Gakis G
    J Urol; 2017 Feb; 197(2):385-390. PubMed ID: 27569436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis.
    Berlin A; Castro-Mesta JF; Rodriguez-Romo L; Hernandez-Barajas D; González-Guerrero JF; Rodríguez-Fernández IA; González-Conchas G; Verdines-Perez A; Vera-Badillo FE
    Urol Oncol; 2017 Aug; 35(8):499-506. PubMed ID: 28648414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive surgical margin is associated with biochemical recurrence risk following radical prostatectomy: a meta-analysis from high-quality retrospective cohort studies.
    Zhang L; Wu B; Zha Z; Zhao H; Jiang Y; Yuan J
    World J Surg Oncol; 2018 Jul; 16(1):124. PubMed ID: 29970100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis.
    Desnoyers A; González C; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
    Mol Diagn Ther; 2020 Apr; 24(2):143-151. PubMed ID: 32100239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.
    Hoogland AM; Verhoef EI; Roobol MJ; Schröder FH; Wildhagen MF; van der Kwast TH; Jenster G; van Leenders GJ
    Prostate; 2014 May; 74(5):488-96. PubMed ID: 24375374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.